FOLH1 and pneumonia: Indirectly targeting PSMs by blocking the Agr system with an RNAIII-inhibiting peptide resulted in a decreased bacterial burden and a lower mortality rate in a mouse pneumonia model, along with reduced expression levels of agr, psmα and psmβ [83].